Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1499 of 6351
-
Can tylenol and toradol replace opioids for ventilated kids?
Symptom relief Recruiting nowIn this clinical trial, investigators want to learn more about using non-opioid pain medications for children with acute respiratory failure. Right now, doctors give these children opioids to help with pain while they are on the ventilator, but investigators don't know if this is…
Phase 3 • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
New drug aims to control rare blood disorders without lifelong steroids
Disease control Recruiting nowThis study will evaluate the safety and efficacy of tafasitamab in adult participants with primary autoimmune blood cell disorders.
Phase 2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Heart bypass patients may benefit from common arthritis drug
Disease control Recruiting nowThis is a single-center, prospective, randomized, open-label, assessor-blinded, blank-controlled exploratory (pilot) trial evaluating the feasibility of oral colchicine after coronary artery bypass grafting (CABG). Graft failure and cardiovascular events remain common after CABG,…
Phase 4 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a simple test unlock better ARDS treatments?
Knowledge-focused Recruiting nowAcute respiratory distress syndrome (ARDS) is a common and life-threatening condition in intensive care units, characterized by substantial biological and clinical heterogeneity. Differences in patients' inflammatory responses, baseline immune function, and organ failure patterns…
Sponsor: Southeast University, China • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control Recruiting nowThe purpose of the study is to evaluate the dose-response relationship of galvokimig compared with placebo in study participants with moderate-to-severe atopic dermatitis (AtD).
Phase 2 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Zap away Parkinson's tremors? new brain stimulation shows promise
Symptom relief CompletedThe goal of this clinical trial is to learn whether a type of brain stimulation called transcranial temporal interference stimulation (TIS) of the internal globus pallidus (GPi) can help improve movement symptoms in people with Parkinson's disease. The study will also look at how…
Sponsor: Shanghai University of Sport • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Can exercise make Weight-Loss drugs work better?
Disease control Not yet recruitingObesity is a growing global health problem that affects people of all ages. It can lead to serious health issues such as cardiovascular disease, insulin resistance, inflammation, and reduced physical function. New medications, including GLP-1 receptor agonists like semaglutide an…
Sponsor: Istanbul Galata University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can brain training ease anxiety in women with recurrent miscarriage?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn whether right dorsolateral prefrontal cortex (right DLPFC)-targeted fNIRS-BCI online closed-loop neurofeedback, delivered with slow-wave acoustic cueing, can reduce anxiety symptoms and improve cardiac autonomic regulation in women with…
Sponsor: Shenyang Medical College • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New drug targets fatty liver in transplant patients
Disease control Recruiting nowA Phase 2 double-blind, randomized, placebo-controlled study to evaluate resmetirom in 2 cohorts of subjects with moderate to advanced fibrosis, consistent with stage F2 and F3 fibrosis, who have undergone liver transplant. Cohort 1 will consist of patients who have undergone liv…
Phase 2 • Sponsor: Madrigal Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Desk-bound pain relief: can targeted exercise untangle chronic neck strain?
Symptom relief CompletedThis clinical trial aims to learn if a structured exercise intervention helps treat chronic neck pain, reduce neck disability, relieve work-related stress, and improve overall quality of life in office workers. The main questions it aims to answer are: Does a targeted exercise …
Sponsor: Sumaya Sadıgova • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New hope for duchenne: Long-Term drug safety trial underway
Disease control By invitation onlyThis is a Phase 2 open-label extension (OLE) study to evaluate the long-term safety, tolerability, efficacy, pharmacokinetics, and the pharmacodynamics (PD) through potential exploratory biomarker(s) of intravenous (IV) WVE-N531 in patients with DMD who participated in another st…
Phase 2 • Sponsor: Wave Life Sciences USA, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Blood clot and laser combo may tame wisdom tooth pain
Symptom relief CompletedThis randomized double-blind clinical trial aims to evaluate the effects of titanium-prepared platelet-rich fibrin (T-PRF), low-level laser therapy (LLLT), and their combination on postoperative outcomes following surgical extraction of impacted mandibular third molars. Sixty pat…
Sponsor: NEW Cyprus Health and Social Sciences University • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Brain injection trial hopes to tame Parkinson's
Disease control Recruiting nowThe purpose of the study is to evaluate the safety and tolerability of BBM-P002 for stereotactic injection to treat participants with idiopathic Parkinson's Disease (PD) during the dose-limiting toxicity (DLT) observation period.
Phase 1 • Sponsor: Shanghai Xinzhi BioMed Co., Ltd. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New cocktail therapy aims to shrink Hard-to-Treat tumors
Disease control Not yet recruitingThis study is a single-arm, multi-center, prospective clinical study aimed at exploring the efficacy and safety of cetuximab β combined with PRaG regimen in rescuing patients with EGFR-positive advanced refractory solid tumors.
Phase 2 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Gaza teens find hope: Mind-Body groups aim to ease war trauma
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if mind-body skills groups can reduce posttraumatic stress disorder and emotional and behavioral problems in war-traumatized adolescents in Gaza. The main questions it aims to answer are: * Do mind-body skills groups reduce posttrauma…
Sponsor: The Center for Mind-Body Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Prepping the body before transplant: new study tests exercise program to boost recovery
Disease control Not yet recruitingCandidates for hematopoietic stem cell transplantation (HSCT) frequently experience declines in strength, physical function, and quality of life before the procedure. Many also present fatigue, limitations in daily activities, and an increased risk of complications during and aft…
Sponsor: Hospital del Salvador • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New antibody therapy aims to fight rare amyloidosis
Disease control Recruiting nowThis study is a clinical trial aimed at the marketing of TQB2934 for injection. The project plans to enroll 70 subjects, including 13-21 subjects in Phase Ib, to evaluate the safety and preliminary efficacy, pharmacokinetic (PK) characteristics, immunogenicity, and pharmacodynami…
Phase 1/2 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New combo tackles cancer pain and tumors at once
Symptom relief Recruiting nowThis study is for patients with advanced bile duct or pancreatic cancer who are experiencing pain from their disease. The purpose of this research is to learn about the effects of combining a standard pain relief treatment (Celiac Plexus Block) with standard first-line cancer dru…
Sponsor: Tongji Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Gene editing for hepatitis b: researchers track Long-Term safety
Disease control By invitation onlyParticipants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.
Sponsor: Precision BioSciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New asthma drug QL2302 goes Head-to-Head with tezspire in major trial
Disease control Not yet recruitingThe goal of this clinical trial is to compare the efficacy and safety of QL2302 and Tezspire® in patients with uncontrolled severe asthma. The main questions it aims to answer are: * if the efficacy of QL2302 and Tezspire® are similar * if the safety of QL2302 and Tezspire® are …
Phase 3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC